Evidence map›Paper›PMID 22173699›Full record

ArticleJournal of the American Society of Nephrology : JASN2012

Filtration markers may have prognostic value independent of glomerular filtration rate.

Navdeep Tangri, Lesley A Inker, Hocine Tighiouart, Eric Sorensen, Vandana Menon, Gerald Beck, Michael Shlipak, Josef Coresh, Andrew S Levey, Mark J Sarnak

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.Clinical journal of the American Society of Nephrology : CJASN · 2017
    Pooled it
  2. Trial
  3. Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2017
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. GFR estimated with creatinine rather than cystatin C is more reflective of the true risk of adverse outcomes with low GFR in kidney transplant recipients.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  9. Article
  10. Review
  11. Potential relationship between eGFRPhysiological reports · 2021
    Article
  12. A New Panel-Estimated GFR, Including βAmerican journal of kidney diseases : the official journal of the National Kidney Foundation · 2021
    Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Navdeep TangriDepartment of Medicine, Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA.
Lesley A Inker
Hocine Tighiouart
Eric Sorensen
Vandana Menon
Gerald Beck
Michael Shlipak
Josef Coresh
Andrew S Levey
Mark J Sarnak
Tufts Medical Center · USCleveland Clinic · USJohns Hopkins University · USSan Francisco VA Medical Center · US

Funding

Chronic Renal Disease-Individual Patient Meta AnalysisU01DK053869 · NIDDK · TUFTS MEDICAL CENTER · PI LEVEY, ANDREW S · 2005 to 2007
$2.5M
Kidney Function and AgingK23DK081017 · NIDDK · TUFTS MEDICAL CENTER · PI INKER, LESLEY ANN · 2008 to 2012
$902k
MDRD LONG TERM FOLLOW UP STUDYU01DK035073 · NIDDK · CLEVELAND CLINIC FOUNDATION · PI BECK, GERALD J · 1986 to 2004
$650k
Chronic Kidney Disease, Vascular Disease and AgingK24DK078204 · NIDDK · TUFTS MEDICAL CENTER · PI SARNAK, MARK J · 2007 to 2011
$587k
Refining Estimates of Kidney Function in the U.S.U01DK067651 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI CORESH, JOSEF · 2005 to 2007
$377k
CIHRNIDDK NIH HHS K23 DK081017NIDDK NIH HHS K23DK081017NIDDK NIH HHS K24 DK078204NIDDK NIH HHS U01 DK035073NIDDK NIH HHS U01 DK 053869NIDDK NIH HHS U01 DK053869NIDDK NIH HHS U01 DK 067651NIDDK NIH HHS U01 DK067651NIDDK NIH HHS U01 DK 35073
6 · The paper itself

Abstract

Serum levels of creatinine, cystatin C, or β trace protein allow estimation of GFR, but whether these markers contribute additional prognostic information beyond that reflected in GFR is unknown. Here, we analyzed data from the Modification of Diet in Renal Disease study, which provided baseline levels of these markers for 816 participants with a median follow-up of 16.6 years. We examined associations between the reciprocals of these filtration markers and (125)I iothalamate GFR, expressed per SD, with kidney failure and mortality. In univariate analysis, lower GFR and higher levels of each filtration marker associated with a higher risk for all outcomes. After adjustment for GFR in a Cox proportional hazards model, higher creatinine associated with a higher risk for kidney failure but a lower risk for all-cause mortality. Higher cystatin C and β trace protein associated with a higher risk for both kidney failure and all-cause mortality. In models including either cystatin C or β trace protein, the association of GFR with all-cause mortality was no longer significant after the addition of the filtration marker, suggesting the possibility of multicollinearity. In summary, after adjustment for GFR, levels of creatinine, cystatin C, and β trace protein, each remained directly associated with kidney failure but differed with respect to their associations with mortality. These differences may be a result of non-GFR-related associations of filtration markers, residual confounding by GFR, or collinearity between the filtration markers and GFR. β trace protein and cystatin C seem to provide more consistent prognostic information than creatinine.

Indexed as

Glomerular Filtration RateAdultAgedBiomarkersCreatinineCystatin CFemaleHumansIntramolecular OxidoreductasesLipocalinsMaleMiddle AgedPrognosisProportional Hazards ModelsRenal InsufficiencyBiomarkersCreatinineCystatin CIntramolecular OxidoreductasesLipocalinsprostaglandin R2 D-isomerase

Identifiers

PMID22173699
PMCPMC3269188
OpenAlexW2133150404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.